European Cancer Organisation shared on LinkedIn:
“Eliminating cancers linked to hepatitis B requires more than effective medical tools. It also means ensuring that everyone can access prevention, diagnosis and care without facing stigma or discrimination.
At today’s European Cancer Summit, one of our key spotlights is on our new policy action report, highlighting how stigma can discourage people from seeking testing, accessing healthcare and continuing treatment.
The discussion also draws on the recent Good Practice Guide on HPV Vaccination, offering practical approaches to closing vaccination gaps across Europe.
‘I lost part of my lung, but I didn’t lose my voice. Stigma lives in silence, and every time we speak about it in public, it loses power.’
– said Anne de Middelaer, Co-Chair, European Network of Gynaecological Cancer Advocacy Groups (ESGO ENGAGe).
The message is clear: eliminating preventable cancers requires effective policies, accessible services and trust between communities and healthcare systems.
- Explore the new hepatitis B, stigma and liver cancer report.
- Discover the Good Practice Guide on HPV Vaccination.”
You may also be interested in: A New Era in Cervical Cancer Prevention in Algeria: Integration of HPV Vaccination into the National Immunization Program
